Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?

ABSTRACT:

Purpose

Stereotactic body radiotherapy (SBRT) has become an excellent non-invasive alternative for many patients with primary renal cell carcinoma (RCC) and adrenal malignancies (AM). The aims of this study were to analyse how tumor-, patient- and treatment-related factors may influence the outcomes and side effects of SBRT and to assess its benefits as an alternative to surgery.

Methods

This retrospective, multicenter study included 25 lesions in 23 patients treated with SBRT using different devices (LINAC, CyberKnife^® and Tomotherapy^®). A multivariate linear regression was used for the statistical study.

Results

Local control time was higher than six months in more than 87% of patients and treatment response was complete for 73.68%. There was a

SUBMITTER: Rivas D 

PROVIDER: S-EPMC11269452 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature